<qa>  What is the rate of stable engraftment of donor cells in patients with re- Determine the rate of stable engraftment of donor cells in patients with relapsed non-Hodgkins or Hodgkins lymphoma treated with a reduced toxicity conditioning regimen followed by allogeneic sibling or unrelated bone marrow transplantation. 